Cargando…
Serum markers in early-stage and locally advanced melanoma
The identification of prognostic factors in cutaneous melanoma allows choosing the most effective treatment, especially in group of patients with locoregional disease. Markers related to carcinogenesis and angiogenesis in particular have effect on the course of the disease. The aim of this study was...
Autores principales: | Lugowska, Iwona, Kowalska, Maria, Fuksiewicz, Małgorzata, Kotowicz, Beata, Mierzejewska, Ewa, Koseła-Paterczyk, Hanna, Szamotulska, Katarzyna, Rutkowski, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672018/ https://www.ncbi.nlm.nih.gov/pubmed/26002577 http://dx.doi.org/10.1007/s13277-015-3564-2 |
Ejemplares similares
-
Comparison of seventh and eighth edition of AJCC staging system in melanomas at locoregional stage
por: Teterycz, Pawel, et al.
Publicado: (2019) -
Trametinib: a MEK inhibitor for management of metastatic melanoma
por: Lugowska, Iwona, et al.
Publicado: (2015) -
Immune-Related Thyroid Adverse Events Predict Response to PD-1 Blockade in Patients with Melanoma
por: Dawidowska, Anna, et al.
Publicado: (2022) -
The analysis of the long-term outcomes of sorafenib therapy in routine practice in imatinib and sunitinib resistant gastrointestinal stromal tumors (GIST)*
por: Rutkowski, Piotr, et al.
Publicado: (2017) -
The Assessment of Clinical Usage and Prognostic Value of YKL-40 Serum Levels in Patients With Rectal Cancer Without Distant Metastasis
por: Fuksiewicz, Malgorzata, et al.
Publicado: (2018)